aid: grey-wolf-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/grey-wolf-therapeutics.png
name: Grey Wolf Therapeutics
description: Grey Wolf Therapeutics (Greywolf Therapeutics) is a clinical-stage biotechnology company
  developing a new therapeutic class of immunotherapies through antigen modulation, aimed at treating
  people living with cancers and autoimmune disorders. Its approach modulates antigen presentation on
  cell surfaces so T cells can correctly recognize and target diseased cells, and it is pioneering
  modulation of Signal 1 in the T cell activation cascade. Lead assets include GRWD5769, a first-in-class
  oral ERAP1 inhibitor for oncology in Phase 1/2 trials, and GRWD0715, an autoimmunity-focused asset also
  in Phase 1/2. Backed by Canaan Partners, the company was added to the API Evangelist network as a
  venture-portfolio company profile. It is a corporate/scientific organization and publishes no public
  developer API, OpenAPI, SDK, or developer portal.
url: https://raw.githubusercontent.com/api-evangelist/grey-wolf-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Immuno-oncology
- Immunotherapy
- Antigen Modulation
- ERAP1
- Autoimmune
- Oncology
- Clinical Stage
apis: []
common:
- type: DomainSecurity
  url: security/grey-wolf-therapeutics-domain-security.yml
- type: Website
  url: https://greywolftherapeutics.com/
- type: Blog
  url: https://greywolftherapeutics.com/latest-news
- type: Support
  url: https://greywolftherapeutics.com/contact-us
- type: PrivacyPolicy
  url: https://greywolftherapeutics.com/privacy-policy
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence